ANXA2 and ovarian carcinoma: A more recent study evaluated the immunostaining of both ANXA2 and S100A10 in a large cohort of epithelial ovarian cancer tissue samples and found that enhanced expression of both proteins in the stroma was associated with reduced OS [199].